|
| Time | Wednesday Sep 21 |
9:00 | Registration opens |
11:30 | Opening |
11:45 | Keynote: Andrea De Luca |
12:35 | Comprehensive bioinformatic analysis of HIV-1 protease specificity |
13:00 | Fold predictions of HIV-1 p1 RNA from therapy-naive and -experienced patients suggest contribution to drug resistance |
13:25 | Modelling in-vivo HIV evolutionary mutational pathways under AZT-3TC regimen through Markov Chains |
14:00 | Lunch |
15:00 | Keynote: Anne-Mieke Vandamme |
15:50 | Virus dynamics: Basic and detailed models of influenza A virus replication in mammalian cells |
16:15 | Modelling molecular evolution of influenza |
16:40 | Coffee |
17:10 | Keynote: Alan Scott Lapedes |
18:00 | Posters |
19:00 | End |
| Time | Thursday Sep 22 |
09:00 | Keynote: Ralf Bartenschlager |
09:50 | Genetic variability and relatedness of hepatitis C virus strains and their effects on liver fibrosis progression |
10:15 | The European hepatitis C virus data base |
10:40 | Amino acid variations in HCV p7 and sensitivity to antiviral combination therapy with amantadine in chronic hepatitis C |
11:10 | Coffee |
11:40 | Keynote: Sergio Abrignani |
12:30 | Posters |
14:00 | Lunch |
15:00 | Keynote: Giovanni Migliaccio & the HCV antiviral team |
15:50 | viRgil: An integrated interdisciplinary European Network of Excellence |
16:15 | Detection and analysis of drug resistance mutations: Bioinformatics challenges and solutions. |
16:40 | Coffee |
17:10 | Keynote: Paul Ahlquist |
18:00 | Posters |
19:00 | End |
| Time | Friday Sep 23 |
09:00 | Keynote: Niko Beerenwinkel |
09:50 | Structure based analyses of HIV PI-resistance |
10:15 | Treatment history improves the accuracy of neural networks predicting virologic response to HIV therapy |
10:40 | Probabilistic modeling of genetic barriers enables reliable prediction of HAART outcome at below 15% error rate |
11:10 | Coffee |
11:40 | Keynote: Alexander E. Gorbalenya |
12:30 | Panel |
14:00 | Lunch |
15:00 | End |